Four partially overlapping mRNAs (1.9, 2.3, 3.9, and 4.5 kilobases [kb]) were located between 0.16 and 0.19 map units on the herpes simplex virus type 1 genome. Their direction of transcription was found to be from right to left. The 2.3-kb mRNA was found to be early (1), whereas the others were late (P3y). Partial sequence analysis of the DNA encoding these genes indicated that the promoter for the 2.3-kb mRNA shares structural features with other early (1) promoters. In vitro translation of hybrid-selected mRNA indicated that among the proteins these mRNAs encode are an 82,000-dalton (d) polypeptide reactive with a monoclonal antibody against herpes simplex virus type 2 alkaline exonuclease and a 50,000-d polypeptide weakly reactive with a polyclonal antibody made against the capsid protein VP19C. Further experiments suggested that the 2.3-kb mRNA encodes the 82,000-d polypeptide, whereas one (or both) of the larger mRNAs encodes the 50,000-d protein. A novel finding was that the 1.9-kb mRNA appears to share part of the translational reading frame for alkaline exonuclease, but any polypeptide it encodes does not react with the monoclonal antibody to this enzyme.
Four partially overlapping mRNAs (1.9, 2.3, 3.9, and 4.5 kilobases [kb]) were located between 0.16 and 0.19 map units on the herpes simplex virus type 1 genome. Their direction of transcription was found to be from right to left. The 2.3-kb mRNA was found to be early (1) , whereas the others were late (P3y). Partial sequence analysis of the DNA encoding these genes indicated that the promoter for the 2.3-kb mRNA shares structural features with other early (1) promoters. In vitro translation of hybrid-selected mRNA indicated that among the proteins these mRNAs encode are an 82,000-dalton (d) polypeptide reactive with a monoclonal antibody against herpes simplex virus type 2 alkaline exonuclease and a 50,000-d polypeptide weakly reactive with a polyclonal antibody made against the capsid protein VP19C. Further experiments suggested that the 2.3-kb mRNA encodes the 82,000-d polypeptide, whereas one (or both) of the larger mRNAs encodes the 50,000-d protein. A novel finding was that the 1.9-kb mRNA appears to share part of the translational reading frame for alkaline exonuclease, but any polypeptide it encodes does not react with the monoclonal antibody to this enzyme.
We have established in a number of recent publications (reviewed in reference 35) that herpes simplex virus type 1 (HSV-1) mRNAs map relatively simply on the viral genome. Furthermore, the low frequency and relatively short span of the characterized HSV-1 introns suggest that the correlation of specific transcripts with genetic markers and known viral proteins will be generally straightforward. Thus, HSV transcription maps add a valuable further dimension to high-resolution genetic marker localization.
As described in the most recent available genetic mapping report (S. K. Weller, W. R. Sacks, D. M. Coen, and P. A. Schaffer, Virology, in press), five complementation groups map in the region between 0.1 and 0.2 map units on the P arrangement of the HSV-1 genome. Details of the data mapping these groups are presented in that publication. Two characterized viral proteins have been located in this region. The first is alkaline exonuclease, an important enzyme of HSV-induced DNA replication (10, 16, 25, 26, 33) . Preston and Cordingley (29) mapped this by measuring enzyme levels of in vitro translation products of hybrid-selected mRNA and by performing hybrid-arrested translation. The second viral protein characterized is a 50,000-dalton (d) capsid protein (VP19C) located by Lemaster and Roizman (20) , using intertypic recombinants.
Recent work (L. Banks, D. J. M. Purifoy, R. A. Killington, and K. L. Powell, J. Gen. Virol., in press) has led to the isolation of several monoclonal antibodies against HSV-2 alkaline exonuclease, some of which are crossreactive with the HSV-1-induced enzyme. Previously reported work (5) described the preparation of polyclonal rabbit antisera reactive with a 50,000-d capsid protein (NC-2 in that publication), which can be inferred to be VP19C. This protein appears to be located on the capsid vertices (34) .
In the present study, we used these antisera to identify the mRNA encoding the alkaline exonuclease as a 1 (early) one and, tentatively, a Py (late) mRNA as encoding the capsid protein.
High-resolution mapping of these mRNAs indicated that all are partially colinear. Correlation of transcript location with nucleotide sequence data demonstrated that the 5' end of the , mRNA lies downstream of a 120-base region sharing certain features with promoters for other ,B HSV-1 mRNAs. Another mRNA was found to be colinear with the 3' portion of the alkaline exonuclease mRNA. It appeared to have its own independent 5' end and was temporally a 3-y mRNA. Preliminary data suggested that this mRNA can be translated in vitro to yield a polypeptide smaller than alkaline exonuclease. Such a polypeptide was not reactive with the Ql antibody, but partial sequence analysis suggested that it is encoded by the same translation frame as the alkaline exonuclease.
MATERIALS AND METHODS Cells and virus. For RNA preparation, plaque-purified isolates of the KOS strain of HSV-1 were used to infect HeLa cells. Monolayer cultures of HeLa cells were grown at 37°C in Eagle minimal essential medium containing 10% calf serum, penicillin, and streptomycin. HSV-2 alkaline exonuclease was prepared from human epidermoid carcinoma no. 2 (HEp-2) cells grown in the same medium. HSV-2 was the 186 strain.
Enzymes. All restriction enzymes were obtained from Bethesda Research Laboratories. Digestions were carried out in buffers recommended by the supplier. Phage T4 polynucleotide kinase (Bethesda Research Laboratories) was used for 5' end labeling as described by Maxam and Gilbert (23) . Escherichia coli DNA polymerase I (Klenow fragment, BoehringerMannheim) was used to generate 3'-end-labeled restricted DNA by procedures described by Maniatis et al (21) .
Isolation, labeling, and size fractionation of polyribosomal RNA. Monolayer cultures of HeLa cells (2 x 107 cells per flask) were infected for 30 min at a multiplicity of 10 PFU of virus per cell in phosphate-buffered saline containing 0.1% glucose and 1.0% fetal calf serum. Polyribosomes were isolated from the cytoplasm of HSV-1-infected cells by the magnesium precipitation method of Palmiter (27) . Polyadenylic acidcontaining [poly(A)] mRNA was isolated from total rRNA by oligodeoxythymidylic acid-cellulose (Collaborative Research, Inc.) chromatography. This is referred to as HSV poly(A) mRNA. Details of this procedure were presented elsewhere (13) . RNA was isolated at 6 h postinfection except when early (,) RNA was required. Then cells were preincubated for 1 h and treated for 5 h with 1.5 x 1i-' M adenosine arabinoside and 3.7 x 106 M pentostatin to inhibit viral DNA replication, as described previously (15) . RNA was size fractionated by electrophoresis on 1.4% agarose gels containing 10 mM methylmercury hydroxide (3) as previously described (1, 2) .
Recombinant DNA. All recombinant DNA clones described in this paper were derived from either HindIII fragment IO (map units 0.082-0.182), HindlIl fragment J (0.182-0.261). XhoI-HindIII fragment C'-10 (0.171-0.182), BamHI-HindIII fragment A-IO (0.152-0.182), or HindIII-SalI fragment J-D (0.182-0.195), cloned in pBR322. Procedures for cloning HSV-1 DNA fragments in the pBR322 vector were described previously (1, 6) . Cloned DNA fragments were named as described previously and located by their map coordinates on the P arrangement of the HSV-1 genome (6).
In situ Northern RNA blots. As described previously, samples (5 ,ug) of HSV poly(A) mRNA were fractionated on methylmercury gels and dried onto Whatman 3mm paper with vacuum (15) . The agarose film was floated off the paper in water and hybridized with appropriate nick-translated, 32P-labeled DNA probes in 50% formamide containing 0.4 M Na+, 0.1 M HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; pH 8.0), 0.005 M EDTA, and Denhardt solution (7) Isolation of restriction fragment-specific mRNA. Restriction fragment-specific mRNA was isolated from HSV poly(A) mRNA by preparative hybridization to the appropriate DNA covalently coupled to cellulose. Details of coupling of DNA to cellulose and preparative hybridization were as described previously (2, 6) .
Nuclease mapping of HSV-1 mRNA. S1 nuclease and exonuclease VII analysis of RNA was carried out essentially as described by Berk and Sharp (4) and as described previously (1, 6, 8, (11) (12) (13) 15) . Appropriate HSV-1 DNA clones (10 ,ug) were cleaved at the desired site with the appropriate restriction enzyme. The DNA then was 5' labeled with [-y-32P]ATP (3,000 Ci/mmol, ICN), using polynucleotide kinase (Bethesda Research Laboratories), to a specific activity of 4,000 to 10,000 cpm/,ug of DNA. Alternatively, the DNA was 3' labeled to the same specific activity by using DNA polymerase I-Klenow fragment (BoehringerMannheim).
The DNA fragments then were denatured and strand separated on 5% acrylamide gels as described by Maxam and Gilbert (23) . The strand-separated DNA (from 10 ,ug of cloned DNA) was hybridized with 10 jig of infected-cell mRNA in 0.1 M Na+-0.1 M HEPES (pH 8.0)-0.01 M EDTA at 65°C for 6 to 16 h in a 30-,u volume. Hybrids were subjected to S1 nuclease (Boehringer-Mannheim) or exonuclease VII (Bethesda Research Laboratories) digestion as described (11, 12) . Material was fractionated on a denaturing 5% acrylamide gel with 5'-end-labeled, HaeII-or HinfI-digested pBR322 DNA fragments as size standards. When the nuclease-protected material was to be fractionated on sequence ladders, mung bean nuclease (PL Biochemicals) was used instead of S1 nuclease. All procedures were based on those of Maxam and Gilbert (23 Immunoprecipitation of in vitro translation products was performed as described previously (13) . One half of the RNase-treated translation product (14 ,u) was diluted with an equal volume of 2x lysis buffer and incubated with 4 ,ul of polyclonal NC-2 serum, a polyvalent antibody to the HSV-1 50,000-d capsid protein (VP19C), or with 1 ,ul of Ql, a monoclonal antibody made against purified HSV-2 alkaline exonuclease. Lysis buffer is 20 mM Tris-hydrochloride (pH 7.4)-S50 mM NaCl-10 mM methionine-0.5% Nonidet P-40-0.5% sodium desoxycholate-0.1% SDS. After 1 h on ice, 50 ,ul of a 10% suspension of Pro-A Sepharose beads (Pharmacia) in 50 mM Tris-hydrochloride (pH 7.5)-150 mM NaCl-5 mM disodium EDTA-0.2% sodium azide was added, and the suspension was incubated for a further 30 min on ice with frequent mixing. The Pro-A Sepharose beads with the immune complex absorbed were then deposited by 1 and any translation product with which it had reacted, was loaded onto SDS-acrylamide gels for size fractionation.
In one set of experiments, we used washed, Formalin-killed Staphylococcus aureus (IgGsorb, The Enzyme Center, Inc., Boston, Mass.) to precipitate the immune complex. This method resulted in a considerably larger amount of protein precipitated but a much higher background of nonspecific radioactive proteins. This procedure, however, yielded interpretable results.
Preparation of radioactive protein markers.
[ (30) . Purity can be assessed from the data in Fig. 3A . . Monoclonal antibodies were prepared by two inoculations of purified enzyme (2 to 3 p.g) into the footpads of BALB/c mice during a 2-week interval. Cell fusion was by the method of Kennett et al. (17) . Hybrid cell colonies were grown in microtiter plates (Linbro) and tested for production of antibody with an enzymelinked immunosorbent assay (horseradish peroxidaseconjugated anti-mouse immunoglobulin G; DAKO, Denmark) using detergent extracts of HSV-2-infected cells as antigen. Peroxidase assay was done with 0.01% orthophenylenediamine and 0.003% hydrogen peroxide.
The antibody used in this paper (Q1) was shown to be able to immunoprecipitate and neutralize the HSV-2 alkaline exonuclease. Furthermore, it has been used in an immunosorbent column to purify the enzyme. It is strongly cross-reactive with the HSV-1-induced enzyme (K. Powell, unpublished data). A Northern blot of viral mRNA isolated from cells in which DNA synthesis was inhibited is shown in Fig. 1A . Here the RNA blot was hybridized with 32P-labeled DNA made by nicktranslating cloned BgIII-XhoI fragment O-G (0.164-0.171 map units). The 2.3-kb mRNA was a major band early, whereas the 1.9-, 3.9-, and 4.5-kb mRNAs were present in low abundance. The same probe revealed the 2.3-kb mRNA in equivalent abundance in Northern blots of late viral mRNA (Fig. IA) . In this RNA, however, the other species were present in relatively greater abundance. This relative abundancy difference with time after infection suggested that the 2.3-kb mRNA is an early (p) mRNA, whereas the 1.9-, 3.9-, and 4.5-kb species are late (P,y) species. Criteria for temporal classification of specific mRNA species have been described in several recent reviews (31, 35, 36) .
RESULTS
We used two nick-translated probes to determine how far the 1.9-kb mRNA extended be- ing to a probe from the 490 bases between the XhoI However, none contained more than 1 to 2% of site at 0.171 and a DdeI site indicated in Fig. 3 and 4 the total radioactivity seen. Furthermore, simi-(below). (C) mRNA species hybridizing to a probe lar experiments (not shown) using DNA 3'-made from HindIII-EcoRI fragment J-D (0.182-0.190 labeled at the BglII site at map unit 0.163 gave a map units).
major S1 protected band 400 bases long. These data, when taken with experiments below, indicated that the four mRNAs share a coterminal 3' yond the XhoI site at map unit 0.171. A probe end ca. 400 bases to the left of the BglII site at extending to a DdeI site 490 bases to the right of 0.163. We did not exclude the presence of small the XhoI site (see sequence data below) hybrid-amounts of other RNA species terminating at ized to all four mRNA species (Fig. IB) . A DNA other sites. probe extending from this DdeI site rightward to
The 5' ends of the 1.9-and 2.3-kb mRNA the HindIII site at 0.182 did not hybridize detect-species were located by hybridizing viral mRNA ably with the 1.9-kb mRNA (not shown).
with strand-separated XhoI-HindIII fragment The two larger P-y mRNAs were readily C'-IO DNA (0.171-0.182 map units) 5' end lashown to extend beyond the HindIII site at map beled at the XhoI site at map unit 0.171. Exonuunit 0.182 since a 32P-labeled DNA probe made clease VII digestion of hybrids (Fig. 2B, track X) from HindIII-EcoRI fragment J-D (0.182-0.190 gave three protected species. One was 1,650 map units) hybridized to them in Northern blots bases long, corresponding to the full length of of late mRNA (Fig. 1C) . As mentioned above, the DNA. This was due to the protection of the other probes were used to show the precise 3.9-and 4.5-kb mRNAs (see below). The second extent of these mRNAs. Heavier exposures of protected fragment was 700 bases long, suggestNorthern blots hybridized with HindIII-EcoRI ing that the 2.3-kb mRNA extends 700 bases to fragment J-D (0.182-0.190 map units) also re-the right of the XhoI site at 0.171. The third vealed a relatively low-abundancy mRNA ca. species was 270 to 280 bases in length. This 2.7 kb in size. This mRNA extended to the right suggested that the 5' end of the contiguous of the area of interest presented in this paper and portion of the 1.9-kb mRNA extends this far to is not characterized here. left of the BgIII site at map unit 0.164. There-However, these were not consistently present in fore, the BglII-XhoI fragment O-G (0.164-0.171 several repeat experiments. We suggest these map units) DNA probe could be expected to were digestion intermediates of the nuclease hybridize with the four mRNAs colinear through reaction. Si nuclease digestion of hybrids bethat region in amounts reflecting their relative tween viral mRNA and strand-separated XhoIabundance. The data of Fig. 1A , then, indicate HindIll fragment C'-IO DNA (0.171-0.182 map that the 2.3-kb (p) mRNA is the most abundant units) 5' end labeled at the XhoI site yielded the mRNA in this region, whereas the 1.9-kb mRNA same three fragments (Fig. 2B, track S) . These is somewhat less so and the 3.9-and 4.5-kb mapping data, the close correlation of the size of the Si-resistant hybrid (ca. 1,880 nucleotides) compared with the total size of the mRNA (2 to 2.1 kb), and the lack of hybridization of DNA probes to the right of the DdeI site to the 1.9-kb mRNA all strongly suggest that this mRNA has a distinct 5' end. Certainly any intron must be less than 50 bases long in total length and must be unable to hybridize efficiently with the DNA under our standard conditions. The 5' ends of the generally colinear 3.9-and 4.5-kb mRNAs were located by using as a hybridization probe strand-separated HindIII-SalI fragment J-D (0.182-0.195 map units) 5 Fig. 3 . A summary of the results of the following experiments and the sequence strategy are shown in Fig. 4 . We precisely located the 5' end of the 2.3-kb mRNA by doing nuclease protection experiments and fractionating the mRNA-protected DNA fragment on a DNA sequencing gel. This procedure has been documented in several previous publications (8, 12, 13 Sequencing was by the method of Maxam and Gilbert (23) , and the strategy is shown in Fig. 4 The sequence data in Fig. 3 were analyzed for potential translational initiation and termination codons. The 5' end of the 2.3-kb (1) mRNA is 160 bases upstream of the canonical eucaryotic translation initiation sequence AAATGG (nucleotides 432 to 437), as described by Kozak (18) . This translation frame (frame 1 of Fig. 4) Fig. 3) to labeled at the XhoI site (base 28; Fig. 3 ) and nd labeled at extending to the DdeI site at base 520, with viral 'bridized with mRNA and carried out Si nuclease analysis.
with S1 nucle-Two protected species were seen. One migrated ed on a dena-with a size of 290 bases, and one migrated along pBR322 DNA with undigested DNA (Fig. SB) . The shorter DNA species corresponded to the 270-to 280-base band seen in Fig. 2B (tracks S and X). The full-length band indicated that no other major 'he compari-species was seen in the region extending up to f five well-520 bases upstream of the XhoI site at 0.271. Fig. 6 . This
Control experiments (not shown) indicated )nfidence in that S1 nuclease-protected DNA was entirely of the 5' end dependent on the presence of viral mRNA in the promoter.
hybridization. We precisely located the mRNA We purified mRNA encoded in this region of HSV-1 DNA by using BamHI-HindIll fragment A-IO (0.152-0.182 map units) and XhoI-HindIII fragment C'-IO (0.171-0.182 map units) bound to cellulose. Both fragments hybridized to all mRNAs (see Fig. 1 ), but the former fragment also encodes the 3' region of another 2-kb mRNA whose 5' end maps near 0.147 and whose 3' end maps near 0.160 (data not shown). We subjected a sample of purified mRNA (ca. 0.1 p.g of total mRNA) to in vitro translation by using
[35S]methionine and incubated the total translation mix with Ql. Reactive protein was size fractionated on a denaturing SDS-acrylamide gel (Fig. 7B , tracks C'-IO and A-IO). Both mRNA preparations translated the same 82,000-d polypeptide. In vitro translation of HSV-1 mRNA purified by using DNA fragments from other regions of the genome did not yield any detectable protein reactive with Qi antibody (data not shown).
In another experiment, we purified mRNA by using XhoI-HindIII fragment C'-IO (0.171-0.182 map units) and translated it in vitro. Translation products were reacted with Ql antibody. This
FIG. 7. In vitro translation and identification of
HSV-1 alkaline exonuclease. All autoradiographs are of denaturing SDS-acrylamide gels (19) . Sizes of proteins (X103 d) were determined by comigration with adenovirus mRNA translation products (not always shown) as described previously (1) material was then subjected to denaturing gel electrophoresis along with purified, 125I-labeled HSV-2 alkaline exonuclease which had also been immunoprecipitated with Ql antibody (Fig.  7C) . This experiment confirmed the essential comigration of the HSV-1 in vitro translation product with authentic HSV-2 alkaline exonuclease.
The experiments described above established the fact that one of the four mRNAs located in the region between 0.160 and 0.190 map units encodes HSV-1 alkaline exonuclease. We translated size-fractionated total HSV-1 mRNA and used Ql antibody to obtain a precise size for the mRNA encoding the enzyme. We size fractionated 10 ,ug of HSV poly(A) mRNA on a denaturing agarose gel. Four mRNA pools were taken, migrating with sizes between 5.2 and 4 kb, 3.7 and 3.1 kb, 2.9 and 2.5 kb, and 2.3 and 2 kb. Each was eluted, reselected on oligodeoxythymidylic acid-cellulose, and subjected to in vitro translation. The translation products were then reacted with Ql antibody. It was clear (Fig. 7D ) that major synthesis of the 82,000-d alkaline exonuclease is mediated by mRNA in the size range of 2.9 to 2.5 kb. These data demonstrate that the 2.3-kb ,B mRNA does, indeed, encode the enzyme. [Note: as in Fig. 1 , this mRNA migrates with a rate corresponding to a size of 2.5 kb because of the poly(A) tail.] The radioactivity migrating at -50,000 d in each track is an endogenous band from the reticulocyte system. Its presence here is due to the fact that we used IgGsorb instead of Pro-A Sepharose to react with the immune complex because of the former's greater ability to bind to immune complexes.
Identification of a potential translation product for the 1.9-kb mRNA. Partial sequence data (Fig.  3) indicated that the 1.9-kb mRNA colinear with the 3' region of the 2.3-kb mRNA could encode a polypeptide about 130 amino acids shorter than the alkaline exonuclease. We used BamHIHindIlI fragment A-TO (0.152-0.182 map units) bound to cellulose to isolate all the mRNAs encoded in the region of interest. We size fractionated these region-specific mRNAs and translated both the 2.3-kb and 1.9-kb mRNAs in vitro. We used methods described in detail in several recent publications (see reference 13) for the size fractionation of the hybrid-selected mRNA. Translation of the 2.3-kb mRNA yielded a number of polypeptides, but only the 82,000-d alkaline exonuclease was reactive with Ql antibody (Fig. 8, tracks T-1 and Q1-1) .
The mRNA isolated as the 1.9-kb species actually contains both this mRNA and a 1.9-kb mRNA which is homologous to the other DNA strand and has a 3' region homologous to the region between 0.152 and 0.160 map units (see The 2.3-kb and 1.9-kb hybrids, selected by using BamHI-HindIII fragment A-IO (0.152-0.182 map units) bound to cellulose, were fractionated by electrophoresis on a denaturing agarose gel containing methylmercury hydroxide. Each was translated in vitro; half of each translation product was fractionated without further treatment (tracks T), and half was reacted with Ql monoclonal antibody (tracks Q1). Details of the translation and fractionation of products are as described for Fig. 7 . A track of the translation product of rabbit globin mRNA is included as a control. the preceding section). Translation of this mRNA mixture consistently gave two polypeptide products distinct from endogenous bands found in the translation system. The larger migrated with a rate corresponding to a molecular weight of 60,000, and the smaller migrated with a rate corresponding to 54,000 (Fig. 8, track T-2) . We suggest that one of these polypeptides is the translation product of the 1.9-kb mRNA in question. Since, however, neither product reacted with Ql antibody (Fig. 8, track Q1-2) , our identification of a translation product for the 1.9-kb mRNA described in this report is only tentative.
Tentative evidence that a 50,000-d HSV-1 capsid protein is encoded by either the 3.9-or 4.5-kb mRNA. We used a polyclonal rabbit antiserum made against the SDS gel-purified 50,000-d HSV-1 capsid protein (VP19C) to tentatively identify it as a translation product of the 3.9-or 4.5-kb mRNA. This antiserum (NC-2) specifically reacts with a 50,000-d protein from [35S]methionine-labeled extracts from HSV-1-infected cells. A denaturing acrylamide gel size fractionation of infected-cell protein reactive with NC-2 is shown in Fig. 9A (track NC2-I Fig. 9A (track NC2-AIO).
The band of radioactivity migrating at 82,000 d is alkaline exonuclease, which is also translated from this mixed mRNA preparation (see above). We could not determine whether this ability of NC-2 antiserum to react with this enzyme was due to specific immunological cross-reactivity. Fig. 3 .
The relative specificity of the NC-2 antiserum, as well as the comigration of immunoprecipitated infected-cell 50,000-d capsid protein and the in vitro translation product (compare Fig. 9A , tracks NC2-I.P. and NC2-AIO), suggested that the mRNA for this protein is either the 3.9-kb or the 4.5-kb (P3y) mRNA mapped in Fig. 2 . This identification must be regarded as tentative, however, since the amount of radioactivity isolated in the 50,000-d translation product precluded tryptic peptide comparison with the purified capsid protein. The relatively small amount of protein recovered from the in vitro translation product could be due to any combination of three factors. First, total translation product contains a relatively small amount of the 50,000-d protein, equivalent to endogenous products of translation (data not shown). This reflects the fact that neither of the two mRNAs is highly abundant. Second, the methionine content of the protein is unknown and may be low. Third, the NC-2 antiserum was made against denatured 50,000-d capsid protein and may not react efficiently with protein translated in vitro.
We confirmed our inference that either the 3.9-kb or 4.5-kb (B-y) mRNA encoded a 50,000-d polypeptide in two ways. First, we used HindIII-Sall fragment J-D (0.182-0.192 map units) DNA bound to cellulose to purify the 3.9-kb and 4.5-kb mRNAs away from the 2.3-kb mRNA for alkaline exonuclease (see Fig. 1 ). Such hybrid purified mRNA, when translated in vitro, yielded the 50,000-d protein immunoreactive with NC-2 antiserum (Fig. 4B) Fig. 2 is entirely consistent with the picture of HSV-1 gene expression and gene packaging developed in the last several years (reviewed in reference 35). The fact that the mRNAs characterized can be correlated with specific viral genes demonstrates, again, the genetic resolution available through HSV transcription mapping. We should note at the outset, however, that none of the data presented here precludes the presence of small amounts of other transcripts in this region being generated via splicing from other promoters or by use of other polyadenylation sites.
Our confidence in the identification of the 2.3-kb a mRNA as encoding alkaline exonuclease is quite high. The immune reactivity with the highly specific monoclonal antibody Ql is, itself, strong evidence, especially when migration of the in vitro translation product is compared with that of authentic enzyme and with that seen in the infected cell (Fig. 7) . The fact that Preston and Cordingley (29) also located the gene for this important enzyme in this region adds to the already strong case. It should be noted, however, that these workers estimated the mRNA for the enzyme to be in the size range of 3.6 kb, considerably greater than that seen here. Their result could be due to the procedures used to fractionate the RNA (sucrose gradients). It could be due, however, to the amphibian oocyte system they used for translation being able to initiate translation in the interior of the partially colinear 3.9-and 4.5-kb mRNAs. Based on the present data, we conclude that these mRNAs contain all the information for the alkaline exonuclease downstream of their translational reading frames. Such patterns of long untranslated regions of some large HSV-1 mRNAs have been described by us previously.
Our confidence in the conclusion that the 50,000-d capsid protein VP19C is encoded by either the 3.9-or 4.5-kb mRNA is not as high. Certainly, these mRNAs encode a protein migrating at 50,000 d, but the relatively weak reaction between the NC-2 antiserum and the in vitro translation products must indicate some caution. It is conceivable (although unlikely) that the precipitation of the translation product by this antiserum is nonspecific. The fact that the capsid protein has been mapped in this general location (20) appears to make this possibility even less likely.
The partial sequence analysis presented here, and further sequence analysis currently under way in this laboratory, are useful in defining potential promoters and translational reading frames. Our location of the 5' end of the 2.3-kb alkaline exonuclease mRNA is quite solid and places this mRNA immediately downstream of a 120-base sequence containing features of HSV-1 1 promoters. We first noted the similarity between another ,B promoter (for the 5.2-kb mRNA mapping in HindIII fragment K) and that for HSV-1 tk several years ago (12) . Subsequent studies have tended to confirm the general features noted. These studies have been reviewed, but the data of Fig. 6 are the most complete comparison available at this time.
It is clear from the analysis of the potential reading frames summarized in Fig. 4 that there is no apparent shared reading frame for the 82,000-d alkaline exonuclease and the 50,000-d VP19C. This is consistent with results from other regions of the genome containing partially colinear mRNAs. We cannot be absolutely certain that translation frame 1 of Fig. 4 does indeed encode the alkaline exonuclease, nor that frame 3 (which initiates further upstream) encodes VP19C. We are certain, however, of our finding of translational stop signals in all three frames before the start signal of frame 1. Furthermore, sequence data not shown indicate that frame 1 stays open for at least several hundred bases downstream of the data shown and that frame 3 stays open for at least the same amount of bases upstream.
Given the size of 2.3 kb as the actual transcript size for alkaline exonuclease and translation frame 1 as its proper frame, we can infer that the total mRNA coding capacity is on the order of 2,100 nucleotides. Such would encode a protein of 700 amino acids, somewhat small for the measured size of alkaline exonuclease (82,000 d). However, there are 37 prolines in the first 236 positions in the predicted amino acid sequence. Such a high proline content (ca. 15%) would lead to a protein migrating .more slowly than predicted from its amino acid residue weight. We have cited this as the reason for the discrepancy between the predicted amino acid residue molecular weight of HSV-1 gC and its migration rate (60,000 d versus 69,000 d; 13).
Partial sequence data (not presented here) around the 5' ends of the 3.9-and 4.5-kb mRNAs suggest that the larger of the two mRNAs encodes a short reading frame which terminates in the leader of the 3.9-kb mRNA. Furthermore, data suggest that the reading frame seen in the 3.9-kb mRNA is open for a significant stretch of nucleotides. Such data indicate that the 3.9-kb mRNA, then, actually encodes the 50,000-d protein that we have suggested is VP19C. This situation would be similar to that seen by Hall et al. (15) for two partially colinear and complementary overlapping mRNAs in the region about map unit 0.7.
The most disturbing aspect of our conclusion that the 50,000-d translation product is actually VP19C is the low abundance of the mRNA. We should state, however, that the amount of
[35S]methionine-labeled VP19C from purified vi-VOL. 48, 1983 on July 6, 2017 by guest http://jvi.asm.org/ Downloaded from rions is very much less than that of VP5 (5) . Also, we have found that the total amount of VP19C recoverable from infected-cell extracts is very much less than that of VP5 by using immune precipitation (Costa and Wagner, unpublished data). Therefore, the amount of VP19C in the infected cell may be low and the abundance of the mRNA encoding it may also be low.
A striking result in terms of HSV-1 mRNA expression of our present study is the finding of a smaller mRNA underlying the 3' three-quarters of the 2.3-kb mRNA and apparently sharing a translational reading frame with it. Other examples of shared translational reading frames are found in the HSV-1 thymidine kinase gene as shown by Marsden et al. (22) and, potentially, in the gC gene (13) .
The sequence data suggest that any protein encoded by the 1.9-kb mRNA should contain the 570 C-terminal amino acids of alkaline exonuclease. This prediction is certainly consistent with the size for either in vitro translation product seen in Fig. 8 . We can assume that the typecommon epitope recognized by the Ql antibody is dependent upon the N-terminal 130 amino acids of the alkaline exonuclease. The properties and possible biological function of any truncated form of the alkaline exonuclease which would lead to its being required at late times after infection are unknown. Indeed, it should be emphasized that such a protein has not been described as being present in normal lytic infection by HSV. Further sequence analysis, as well as further mRNA and protein fractionation procedures currently being undertaken in our various laboratories, may lead to more specific predictions regarding this putative protein. The data do suggest, however, that the partial colinearity of mRNAs under independent temporal or promoter control can be a result of related features of the proteins encoded.
